Macula	macula	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
after	after	O	O	O	O
intravitreal	intravitreal	O	O	O	O
amikacin	amikacin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Although	although	O	O	O	O
intravitreal	intravitreal	O	O	O	O
aminoglycosides	aminoglycosides	CHEMICALS	O	OTHERS	I
have	have	O	O	O	O
substantially	substantially	O	O	O	O
improved	improved	O	O	O	O
visual	visual	O	O	O	O
prognosis	prognosis	O	O	O	O
in	in	O	O	O	O
endophthalmitis	endophthalmitis	O	O	OTHERS	I
,	,	O	O	O	O
macular	macular	O	O	O	O
infarction	infarction	O	DISEASE	OTHERS	I
may	may	O	O	O	O
impair	impair	O	O	O	O
full	full	O	O	O	O
visual	visual	O	O	O	O
recovery	recovery	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
present	present	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
presumed	presumed	O	O	O	O
amikacin	amikacin	CHEMICALS	O	OTHERS	I
retinal	retinal	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
following	following	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
amikacin	amikacin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
vancomycin	vancomycin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
alpha-haemolytic	alpha-haemolytic	O	O	O	O
streptococcal	streptococcal	O	O	OTHERS	I
endophthalmitis	endophthalmitis	O	O	OTHERS	I
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Endophthalmitis	endophthalmitis	O	O	OTHERS	I
resolved	resolved	O	O	O	O
with	with	O	O	O	O
improvement	improvement	O	O	O	O
in	in	O	O	O	O
visual	visual	O	O	O	O
acuity	acuity	O	O	O	O
to	to	O	O	O	O
6/24	6/24	O	O	O	O
at	at	O	O	O	O
three	three	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

Fundus	fundus	O	O	O	O
fluorescein	fluorescein	CHEMICALS	O	OTHERS	I
angiography	angiography	O	O	O	O
confirmed	confirmed	O	O	O	O
macular	macular	O	O	O	O
capillary	capillary	O	O	O	O
closure	closure	O	O	O	O
and	and	O	O	O	O
telangiectasis	telangiectasis	O	O	OTHERS	I
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Currently	currently	O	O	O	O
accepted	accepted	O	O	O	O
intravitreal	intravitreal	O	O	O	O
antibiotic	antibiotic	O	O	O	O
regimens	regimens	O	O	O	O
may	may	O	O	O	O
cause	cause	O	O	O	O
retinal	retinal	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
macular	macular	O	O	O	O
ischaemia	ischaemia	O	O	OTHERS	I
.	.	O	O	O	O

Treatment	treatment	O	O	O	O
strategies	strategies	O	O	O	O
aimed	aimed	O	O	O	O
at	at	O	O	O	O
avoiding	avoiding	O	O	O	O
retinal	retinal	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
are	are	O	O	O	O
discussed	discussed	O	O	O	O
.	.	O	O	O	O

